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1.  Introduction
Diabetic peripheral neuropathy (DPN) is the most 
common late complication of diabetes, often as-
sociated with considerable morbidity and mortality 
[1]. It is estimated that 12−50% of people with dia-
betes have some degree of DPN [2]. Approxi mately 
15% of people with diabetes develop at least one 
foot ulcer during their lifetime [3−4]. While vascular 
disease leading to ischemia is certainly a factor in 
the pathogenesis, 60−70% of diabetic foot ulcers are 
primarily neuropathic in origin [4].
DPN may be asymptomatic. When symptoms are 
present, they may be negative or positive. Nega tive 
symptoms include loss of sensation and strength, 
while positive symptoms include prickling or pain 
[5]. Affected nerve functions include reduced nerve 
conduction velocity, decreased temperature sensa-
tion, decreased tendon reflex response, and a de-
creased ability to detect vibration and touch.
The pathophysiology of DPN remains unclear, 
although it is associated with increased age, duration 
of diabetes, lipotoxicity and glucotoxicity, genetic 
susceptibility, inflammation, and oxidative stress 
[6,7]. The total annual cost of DPN and its compli-
cations in the United States was estimated to be 
more than four billion. Up to 27% of the direct med-
ical cost of diabetes may be attributed to DPN [8]. 
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Although several pivotal trials have shown that 
strict glycemic control reduces the occurrence and 
progression of diabetes-related complications [9,10], 
this approach alone does not completely eliminate 
complications. Thus the development of new therapy 
to manage diabetes complications remains a high 
priority.
Acupuncture, one of the oldest and most com-
monly used forms of alternative medicine, has ex-
isted for more than 2500 years. Acupuncture is a 
meridian-based therapy. In traditional acupuncture, 
needles are inserted into precisely defined, spe-
cific points on the body, each of which has distinct 
therapeutic actions [11]. According to traditional 
Chinese medicine (TCM), when an acupoint is stim-
ulated, treatment effects tend to occur on the 
specific parts of the body along a particular meridian 
that contains this specific acupoint. In vestigators 
have demonstrated that the nervous system and 
neurotransmitters respond to needling stimulation 
and electroacupuncture [12−14]. As a safe form of 
treatment [15,16], acupuncture offers clear clinical 
advantages in the reduction of symptoms related to 
nervous disorders. Paul et al [17] reported that two 
of the total three patients showed increased benefit 
when a series of six acupuncture sessions was added 
to the ongoing nefazodone therapy for the treat-
ment of DPN. Unfortunately, to date, only a few 
trials on acupuncture have specifically targeted 
DPN. In a randomized controlled trial in China, 
Chen et al [18] concluded that the point through 
point method of acupuncture was superior to 
mecobalamin for the improvement of motor nerve 
conduction velocity (MNCV) of the common pero-
neal nerve. The results of another randomized 
trial showed that acupuncture lowered the pain 
caused by painful DPN [19]. Given these findings, 
we also performed a prospective randomized con-
trolled trial to investigate whether acupuncture is 
useful for DPN.
2.  Materials and Methods
2.1.  Study site and participants
The study was conducted at the Jilin Chinese Med-
ical Hospital between June 2005 and December 
2005. DPN patients aged 35−52 years were invited 
to participate.
2.2.  Study protocol
The study protocol was approved by the Jilin 
Chinese Medical Hospital. Protocol summaries 
were reviewed by the participants, and written, 
informed consent was obtained on the day of the 
study after a detailed explanation of the study 
purpose and methods. These participants were diag-
nosed with mild DPN based on subjective symptoms, 
no foot ulceration, and neurological dysfunctions 
(at least two parameters: MNCV [indispensable] 
and vibration perception threshold [VPT] or Achilles 
tendon reflex). MNCV in the tibial nerve of patients 
ranged between 30 m/s and 45 m/s. Participants’ 
sensory nerve conduction velocity (SNCV) in the 
median nerve (the distal area) ranged between 
35 m/s and 55 m/s with stable glycemic control 
(HbA1C ≤ 9%, with ± 0.5% variation in the previous 
3 months). Subjects were excluded if their primary 
cause of neurologic disorder was not diabetes (e.g., 
alcoholic neuropathy, carpal tunnel syndrome, se-
quelae of cerebrovascular disease,), if their F-wave 
response had disappeared, if they had arterioscle-
rosis obliterans (ankle brachial pressure index 
of ≤ 0.8) or severe hepatic or renal disorder, if they 
were participating in other interventional studies, 
or if they were receiving other experimental medi-
cations for DPN, prostaglandin E1 preparations, or 
any other medication that affects symptoms of DPN. 
After the baseline period, 63 participants meeting 
the inclusion criteria were randomized (by random 
number table) into one of the two groups in a 2:1 
ratio (acupuncture group and sham acupuncture 
group) which differed only in the type of needle ma-
nipulation used. This randomization meant 42 cases 
were allocated to the acupuncture group and 21 
cases to the sham acupuncture group. There were 
no statistically significant differences (p > 0.05) be-
tween the two groups in any of the baseline char-
acteristics. Table 1 shows the baseline characteristics 
for all 63 patients.
Both groups continued conventional therapy 
(diet treatment, hypoglycemic agents, insulin and 
hypotensive agents) with medication to aid neu-
ropathy control prohibited. No major changes in 
diabetic management had taken place during the 
3 months before the study, and no therapeutic al-
teration was made throughout the study. All pa-
tients participated in one session per day lasting 
30 minutes for 15 days, during which a total of five 
acupuncture point locations on the body received 
acupuncture needling. Sterile disposable one-time-
use needles were used. For each location, a pair of 
corresponding acupoints on the right and left sides 
of the body were identified and marked with a skin 
marker (10 acupoints total). These acupoints were 
Hegu (LI4), Fenglong (ST40), Quchi (LI11), Zusanli 
(ST36), and San Yin Jiao (SP6) identified by an ex-
perienced acupuncturist (Jianmin Lang) according 
to traditional methods. Approximate position was 
determined in relation to anatomic landmarks (e.g., 
bones, tendons) and proportional measurements 
(e.g., fraction of the distance between wrist and 
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elbow creases) [20]. Within this delineated area, 
the precise position of each acupoint was deter-
mined by palpation, feeling for a slight depression 
or yielding of tissues.
For each acupoint, a needle 0.3 mm in diameter 
and 50 mm in length was used with 1.2−2.3 cm 
penetration, in a direction perpendicular to the 
surface of skin. The depth of insertion was be-
tween 1.20−1.53 cm for LI4, 1.82−2.25 cm for ST40, 
1.38−1.50 cm for LI11, 2.11−2.30 cm for ST36 and 
1.73−2.00 cm for SP6 with achievement of “De qi” 
(a sensory component perceived by the patient as 
an ache or heaviness in the area surrounding the 
needle and another simultaneous component, nee-
dle grasp, perceived by the acupuncturist [20]). The 
needle was then rotated alternately either clock-
wise or counterclockwise every 5 minutes. For sham 
acupuncture treatment, the same acupoints were 
punctured with the same acupuncture needles; how-
ever, the needle was inserted to a depth of only 
0.3 cm, and no manipulation of the needle was per-
formed, to avoid De qi [21]. Number, duration and 
frequency of the sessions in the sham acupuncture 
group were the same as for the acupuncture group. 
At the end of treatment, the success of blinding 
was tested by asking all patients the following ques-
tion: “When you volunteered for the trial, you were 
informed that you had an equal chance of receiving 
acupuncture or sham (pretend) acupuncture. Which 
acupuncture do you think you received?”
The primary end points for clinical efficacy were 
the differences between baseline and post-treatment 
electrophysiological measurements of the median 
motor nerve (F-wave minimum latency, MNCV, and 
F-wave conduction velocity [FCV]), the tibial motor 
nerve (F-wave minimum latency, MNCV, and FCV), 
and the median sensory nerve (forearm SNCV and 
distal SNCV). The method to measure nerve function 
was that according to Kohara et al [22] using elec-
tromyography (DISA1500; DISA, Herlev, Denmark). 
F-wave was measured 16 times, and the minimum 
was adopted. VPT was measured on the medial mal-
leolus in the lower extremities using a hand-held 
biothesiometer (Biomedical Instruments, Newbury, 
OH, USA) [23,24]. The voltage of vibration was in-
creased until the patient could perceive a vibra-
tion. This was conducted three times. The mean of 
these three trials was used to determine the VPT.
Table 1  Baseline characteristics of all patients*
Characteristic Acupuncture (n = 42) Sham acupuncture (n = 21)
Age (yr) 43.5 (5.0) 45.8 (6.2)
Female n (%) 33 (78.6) 16 (76.2)
BMI (kg/m2) 23.5 (0.4) 22.9 (0.3)
Duration of diabetes (mo) 152.0 (13.5) 148.8 (15.3)
Duration of DPN (mo) 25.6 (7.5) 23.5 (8.0)
Type of diabetes n (%)
 Type 1 23 (46.0) 10 (45.5)
 Type 2 27 (54.0) 12 (54.5)
HbA1C (%) 6.8 (1.3) 6.6 (1.2)
MNCV in the tibial nerve (m/s) 39.5 (0.5) 38.8 (0.6)
SNCV in median nerve (distal) (m/s) 48.0 (0.7) 46.1 (0.8)
VPT (s) 8.05 (3.22) 8.04 (3.30)
Medication n (%)
 None 4 (9.5) 2 (9.5)
 Oral hypoglycemic agent 23 (54.8) 11 (52.4)
 Insulin 13 (31.0) 7 (33.4)
 Oral hypoglycemic agent/insulin 2 (4.7) 1 (4.7)
Diabetic proteinuria n (%)
 No 23 (54.8) 10 (47.6)
 Intermittent 12 (28.6) 7 (33.3)
 Persistent 7 (16.6) 4 (19.1)
Previous acupuncture (for any condition) n (%) 23 (54.8) 10 (47.6)
*Values expressed as mean (SD) unless otherwise indicated. BMI = body mass index; DPN = diabetic peripheral neuropathy; MNCV = 
motor nerve conduction velocity; SNCV = sensory nerve conduction velocity; VPT = vibration perception threshold.
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Symptoms were assessed using a standardized 
and comprehensive questionnaire at baseline and 
following 15 days of treatment. The symptoms as-
sessed included measures of numbness, pain, rigid-
ity (rigidity is a state of continuous, firm and tense 
muscles with marked resistance to passive move-
ment), alterations in temperature perception, par-
esthesia, hypesthesia and weakness. For these 
sym ptoms, both the severity and extent were scored 
on an ascending 0−4 scale. For each symptom cate-
gory, data were analyzed for all subjects in the ef-
ficacy pool who reported the symptom during the 
course of the study. Because not all symptoms were 
present in each subject, different subsets of sub-
jects were included for each symptom.
The specific scoring for severity of symptoms was 
as follows: 0 = none (disappeared); 1 = very slight 
(sometimes, but causes no problem at all in daily life); 
2 = slight (always, but causes no problem in daily life); 
3 = moderate (always, sometimes makes daily activ-
ity troublesome); and 4 = severe (it makes daily ac-
tivity troublesome). For the extent of symptoms, the 
scoring was as follows: 0 = none; 1 = only fingertips or 
ends of toes; 2 = from wrist to fingertip or from ankle 
to toe; 3 = from elbow to fingertip or from knee to 
toe; and 4 = from above the elbow or above the knee.
2.3.  Statistical analysis
Statistical methods used included two-sample t tests 
for comparison of mean values between groups, 
paired t tests for comparison of mean values within 
groups, and two-way repeated analysis of variance 
for changes in glycemic control. All analyses were 
carried out using SAS version 8.02 (SAS Institute, 
Cary, NC, USA). A p value < 0.05 was considered sta-
tistically significant.
3.  Results
3.1.  Blinding data
At the end of treatment, all patients were asked 
the following question: “When you volunteered for 
the trial, you were informed that you had an equal 
chance of receiving acupuncture or sham acupunc-
ture. Which acupuncture do you think you received?” 
Of the 63 patients who gave an answer, two (9.5%) 
in the sham group believed that they had received 
sham acupuncture, all in the real acupuncture group 
believed that they had received real acupuncture. 
The blinding index was 0.32 (95% confidence inter-
val [CI], 0.27 to 0.37) in the acupuncture group 
and −0.65 (95% CI, −0.61 to −0.69) in the sham 
group. The two proportions of unblinding were not 
significantly different (p = 0.25).
3.2.  Changes in glycemic control
In the acupuncture group (n = 42), HbA1C (mean ± 
SD) at baseline and day 15 was 6.8 ± 1.3 and 6.7 ± 
1.2% respectively. Corresponding values in the sham 
acupuncture group were 6.6 ± 1.2% and 6.7 ± 1.3%, 
respectively. There were no significant differences 
between the two groups at any time point.
3.3.  Change in nerve function
Table 2 outlines each electrophysiological measure 
(mean ± SD) at baseline and end-of-treatment time 
points. Six measures assessed function in motor 
nerves, including F-wave minimum latency, MNCV 
and FCV in the median and tibial nerves. In the 
acupuncture group, three of the six measures in 
motor nerves demonstrated significant improvement 
(p < 0.05) over the 15-day treatment period. As ex-
pected, no electrophysiological measures of motor 
or sensory function significantly improved in the 
sham acupuncture group.
The two measures of sensory function, forearm 
and distal SNCV, also improved in the acupuncture 
group. The change of forearm SNCV from baseline 
was significant (p < 0.05).
There were also significant differences in VPT be-
tween groups (p < 0.05) and when compared to the 
baseline levels (p < 0.01) in the acupuncture group.
3.4.  Changes in subjective symptoms 
over time
Figures 1−8 show some of the changes in the score 
for subjective symptoms, in which a significant dif-
ference between the two groups was observed. As 
shown in the figures, the difference between the 
two groups gradually increased with continuous 
treatment. Acupuncture was significantly better than 
sham acupuncture for the treatment effects on numb-
ness of lower extremities (severity p < 0.05, extent 
p < 0.05; Figures 1 and 2, respectively), spontaneous 
pain in lower extremities (severity p < 0.05, extent 
p < 0.01; Figures 3 and 4), rigidity in upper extrem-
ities (severity p < 0.05, extent p < 0.05; Figures 5 
and 6), and alterations in temperature perception in 
lower extremities (severity p < 0.01, extent p < 0.05; 
Figures 7 and 8, respectively).
Although the data are not shown in the figures, 
numbness in the upper extremities (severity), and 
sensation of rigidity (extent) were significantly im-
proved in the acupuncture group compared with the 
sham acupuncture group (p < 0.05, and 0.01, respec-
tively) after 15 days treatment. There was no signifi-
cant difference between the two groups in the 
sensation of paresthesia, hypesthesia, and weakness 
of extremities.
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Table 2  Changes in nerve function at baseline and end-of-treatment timepoints
Parameter Acupuncture (n = 42) Sham acupuncture (n = 21) Difference
F-wave minimum latency in median
 Baseline (m/s) 32.5 ± 0.5 32.5 ± 0.3 
 End of treatment (m/s) 32.7 ± 0.4 32.5 ± 0.4 
 Difference (m/s) 0.2 ± 0.2 0.0 ± 0.2 0.2
 95% CI −0.19 to 0.59 −0.39 to 0.39 
F-wave minimum latency in tibial   
 Baseline (m/s) 52.6 ± 0.5 52.5 ± 0.6 
 End of treatment (m/s) 53.0 ± 0.3 52.5 ± 0.7 
 Difference (m/s) 0.4 ± 0.3* 0.0 ± 0.1 0.4
 95% CI −0.19 to 0.99 −0.20 to 0.20 
MNCV in median   
 Baseline (m/s) 40.3 ± 0.3 40.5 ± 0.4 
 End of treatment (m/s) 40.6 ± 0.3 40.4 ± 0.5 
 Difference (m/s) 0.3 ± 0.2 −0.1 ± 0.2 0.4
 95% CI −0.09 to 0.69 −0.49 to 0.29 
MNCV in tibial   
 Baseline (m/s) 39.5 ± 0.5 38.8 ± 0.6 
 End of treatment (m/s) 40.2 ± 3.9 38.8 ± 0.5 
 Difference (m/s) 0.7 ± 0.3† 0.0 ± 0.2 0.7
 95% CI 0.11 to 1.29 −0.39 to 0.39 
FCV in median   
 Baseline (m/s) 55.6 ± 0.4 55.7 ± 0.5 
 End of treatment (m/s) 56.5 ± 0.5 55.8 ± 0.6 
 Difference (m/s) 0.9 ± 0.5† 0.1 ± 0.4 0.8
 95% CI −0.08 to 1.88 −0.68 to 0.88 
FCV in tibial   
 Baseline (m/s) 48.3 ± 0.5 48.3 ± 0.4 
 End of treatment (m/s) 48.8 ± 0.6 48.3 ± 0.5 
 Difference (m/s) 0.5 ± 0.4 0.0 ± 0.3 0.5
 95% CI −0.28 to 1.28 −0.59 to 0.59 
SNCV in median (forearm)
 Baseline (m/s) 47.8 ± 0.5 47.8 ± 0.6
 End of treatment (m/s) 48.3 ± 0.7 47.8 ± 0.6
 Difference (m/s) 0.5 ± 0.3* 0.0 ± 0.5 0.5
 95% CI −0.09 to 1.09 −0.98 to 0.98
SNCV in median (distal)
 Baseline (m/s) 48.0 ± 0.7 46.1 ± 0.8
 End of treatment (m/s) 48.2 ± 0.6 46.2 ± 0.7
 Difference (m/s) 0.2 ± 0.5 0.1 ± 0.3 0.1
 95% CI −0.78 to 1.18 −0.49 to 0.69
VPT
 Baseline (s) 8.05 ± 3.22 8.04 ± 3.30
 End of treatment (s) 8.56 ± 3.43 8.08 ± 3.28
 Difference (s) 0.51 ± 0.70‡ 0.04 ± 0.13 0.47
 95% CI −0.86 to 1.88 −0.21 to 0.29
*p < 0.05 when compared to baseline, and when compared to sham acupuncture (SA) group; †p < 0.01 when compared to baseline 
and when compared to SA group; ‡p < 0.01 when compared to baseline, p < 0.05 when compared to SA group. CI = confidence inter-
val; MNCV = motor nerve conduction velocity; FCN = F-wave conduction velocity; SNCV = sensory nerve conduction velocity; 
VPT = vibration perception threshold.
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Figure 1   Changes in scores for severity of numbness.
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Figure 2   Changes in scores for extent of numbness.
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Figure 3   Changes in scores for severity of pain.
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Figure 4   Changes in scores for extent of pain.
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Figure 5   Changes in scores for severity of rigidity.
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Figure 6   Changes in scores for extent of rigidity.
4.  Discussion
The peripheral nervous system is commonly affected 
in diabetic patients and the sequelae of nerve dys-
function often influence the final outcome of the 
disease. The pathophysiology of DPN remains con-
troversial. Little is known about the etiology of loss 
of peripheral sensory neurons that accompanies 
DPN. Programmed cell death, or apoptosis, has been 
implicated in diabetic retinopathy and neuropathy 
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Figure 7   Changes in scores for severity of alterations 
in temperature perception.
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Figure 8   Changes in scores for extent of alterations in 
temperature perception.
[25], with impaired mitochondrial function being im-
plicated in the promotion of apoptosis [26]. Increased 
polyol pathway activity has also been implicated 
in the pathogenesis of DPN [27].
Acupuncture is a safe form of treatment 
[15,16,28] and offers clear clinical advantages in 
the reduction of DPN related symptoms. This tech-
nique from Chinese medicine dates back at least 
2500 years. According to the theory of Chinese med-
icine, health is a state of balance between yang 
and yin, between Qi and Xue, and between the 
five elements of wood, fire, earth, metal, and water 
[29]. Qi, or life energy, flows through the body in 
hypothesized channels called “meridians” and may 
be accessed at several hundred points. The tradi-
tional theory of acupuncture is based on the con-
cept that an imbalance of yang and yin, through 
the meridians, can be corrected by manipulation 
of identifiable points close to the skin. The skilled 
acupuncturist is able to restore balance by using 
selected acupoints to adjust the energy flow. Each 
acupoint has distinct therapeutic actions. The stim-
ulation of acupoints can be achieved by either a 
mechanical action of needling or electrical point 
stimulation [30].
Acupuncture was performed according to the 
rules of Chinese medicine, including diagnostic pal-
pation to identify sensitive spots [20]. Acupoints 
refer to certain specifically located sites on the body, 
and according to TCM, these different specific 
points can be grouped into different categories in 
terms of their functional properties. Different groups 
of acupoints of the same type of functional prop-
erty, which are located regularly on specific parts 
of the body, are the equivalent of 12 main meridi-
ans that respond to 12 major functions or “organs” 
of the body according to TCM. For DPN related 
symptoms, the most commonly used acupoints are 
Hegu (LI4), Fenglong (ST 40), Quchi (LI11), Zusanli 
(ST36) and San Yin Jiao (SP6).
LI4, as Yuan-Source point, is of great significance 
in treating internal organ disease. LI4 strongly moves 
the Qi and blood in the body to remove stagnation, 
so indicated in every type of sensory or motor nerve 
disorders. The Yuan-source point from the affected 
meridian is often combined with the Luo-Connecting 
point of the internally-externally related meridi-
ans in use. ST40 is known as the Luo-Connecting 
point which can communicate with two meridians. 
ST40 is used to treat collateral disease and can be 
used to treat chronic diseases, especially chronic 
diseases of the Zang-Fu organs. It calms the Shen 
and clears phlegm from the heart by activating the 
meridian. So LI4 and ST40 are often used in combi-
nation for nervous disorders.
LI11 and ST36 are the He-Sea points, where the 
Qi of the meridian collects and goes deep into the 
body. LI11 can clear heat, cool blood, resolve damp-
ness, regulate Qi and blood, and activate the me-
ridian. ST36 tonifies Qi and blood, harmonizes and 
strengthens the spleen and stomach, strengthens the 
body and Wei Qi, raises Yang, and calms the Shen. 
These two acupoints are also proven to be effective 
in nervous disorders.
SP6 is one of the most commonly used points, and 
also one of the most versatile. Because SP6 crosses 
the spleen, kidney and liver meridians, it can treat 
many conditions associated with all three organs. 
This point nourishes blood and yin, cools and invig-
orates the blood, and calms the Shen.
In this randomized trial, randomization was 
successfully concealed, achieving good credibility 
and blinding of participants receiving the nonpen-
etrating acupuncture intervention. The results show 
that acupuncture was more effective than sham ac-
upuncture in improving nerve conduction velocity 
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and a variety of subjective symptoms associated 
with DPN.
F-wave measurements are particularly useful 
because they can detect abnormalities in any region 
of a peripheral nerve [31]. In the present study, 
differences in the reproducibility of F-wave mini-
mum latency and FCV versus NCV measurements may 
account for the greater sensitivity of the former 
for detecting evidence of disease progression and 
acupuncture treatment effects. Also, acupuncture 
showed a significant improvement compared with 
sham acupuncture in F-wave minimum latency in 
tibial nerve measurements, FCV in measurements of 
the median motor nerve and MNCV in tibial nerve 
measurements. Improvement of nerve conduction 
function was considered to result in the effect of 
nerve degeneration, such as axonal atrophy in dia-
betic neuropathy [32]. These results suggest that 
acupuncture can delay the progressive deteriora-
tion of nerve function secondary to DPN.
Although small and not present in every nerve, 
the observed significant changes in electrophysio-
logical measures, combined with the improvement 
in symptoms, is especially encouraging in the dia-
betic population included in the present study. 
During the study, the difference in the subjective 
symptom scores between the acupuncture and sham 
acupuncture groups increased with time. Acupunc-
ture treatment appeared to significantly improve 
subjective symptom scores, particular numbness, 
pain, rigidity and alterations in temperature per-
ception. In DPN, although nerve fiber regeneration 
after nerve fiber loss is frequently observed in pe-
ripheral nerves, the process of regeneration appears 
to be delayed, and thus some regenerated nerve fib-
ers remain immature. Ab normal excitement of these 
immature regenerated nerve fibers is thought to 
lead to numbness and spontaneous pain [33,34]. 
Acupuncture treatment improved these symptoms, 
suggesting that it may accelerate the nerve regen-
erative process in DPN patients.
Blinding indices, 0.32 (95% CI, 0.27 to 0.37) and 
−0.65 (95% CI, −0.61 to −0.69) in the acupuncture 
group and sham acupuncture group, respectively, im-
ply that 32% of patients correctly guessed the treat-
ment identity beyond chance, while 65% of patients 
in the sham acupuncture group incorrectly guessed 
that they had received acupuncture. Following the 
logic of Bang et al [35], these results indicate high 
“response bias”, which implies that a majority of 
study participants tend to believe that they were 
assigned a more effective intervention [36].
As mentioned above, acupuncture treatment 
not only improved nerve conduction velocity de-
creased by DPN, but also improved a variety of 
subjective symptoms associated with this progres-
sive disabling disorder. Our pilot study has shown 
that the effects of acupuncture treatment on sub-
jective symptoms as well as other measures of 
nerve function provide evidence that acupuncture, 
a form of alternative medicine, may be clinically 
useful for the radical treatment of DPN. Further 
studies with larger patient numbers are required 
to confirm our findings, to determine whether the 
effects are sustained, and to ascertain whether 
there are any effects on other sensory symptoms 
associated with DPN.
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